Provides updates of recent ISPOR activities and events.
2018
ISPOR eBulletin (May 2018)
ISPOR eBulletin (April 2018)
ISPOR eBulletin (March 2018)
ISPOR eBulletin (February 2018)
ISPOR eBulletin (January 2018)
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
ISPOR eBulletin Index

March 2009

The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: www.ispor.org. Please share these new ISPOR activities with your colleagues.

 

MEETINGS

ISPOR 14th Annual International Meeting, Orlando, FL, USA-Extended Program – Full Program now available
Health Care Reform Revisited, v2009.1 (beta)
~1200 abstracts submitted – Record High! – Meeting features over 1,000 presentations!

*Early Registration Deadline: April 7, 2009
ISPOR 14th Annual International Meeting Registration >>

Saturday, May 16, 2009
  Saturday Short Courses >>
  Educational Symposia >>
Sunday, May 17, 2009
  Sunday Short Courses >>
  Educational Symposia >>
Monday, May 18, 2009
  Plenary Session I >>
  ISPOR Forums >>
  Educational Symposia >>
  Poster Session I >>
Tuesday, May 19, 2009
  Plenary Session II >>
  ISPOR Forums >>
  Educational Symposium >>
  Poster Session II >>
Wednesday, May 20, 2009
  Plenary Session III >>
  Poster Session III

*For Exhibit and Sponsorship Opportunities, see:
ISPOR 14th Annual International Meeting >>

ISPOR 2nd Latin America Conference, Rio de Janeiro, Brazil
Abstract submission is now open!  The ISPOR 2nd Latin America Conference will be held 10-12 September 2009 at the Sheraton Rio Hotel, Rio de Janeiro, Brazil.   Abstracts are invited in English, Spanish & Portuguese.  For more information on program content, exhibit and support opportunities, see:
ISPOR 2nd Latin America Conference >>

Abstract Submission Deadline: 19 March 2009

ISPOR 12th Annual European Congress, Paris, France

The ISPOR 12th Annual European Congress will be held 24-27 October, 2009 at Le Palais des Congrès de Paris, Paris, France.

Abstract submission deadline is 23 June 2009.Abstract submission opens 23 March 2009. For abstract submission instructions, see:
ISPOR 12th Annual European Congress Abstract Submission Instructions >>

Preliminary Program

Saturday, 24 October 2009

  Short Courses >>
Sunday, 25 October 2009
  Short Courses >>
  Plenary Session I: Health Care Reimbursement Systems in Europe: Learning from Each Other
Monday, 26 October 2009
  Plenary Session II: Risk-Sharing Agreements - Theory to Practice: Are They Working?
Tuesday, 27 October 2009
  Plenary Session III: Involving the Patient in Health Care Decisions
Sponsorship, Exhibit, and Symposium Opportunities, see:
ISPOR 12th Annual European Congress >>


VALUE IN HEALTH

 

NEW! Value in Health Volume 12, Issue 2 On-Line

Value in Health Volume 12, Issue 2 is now available on-line.

NEW! Value in Health Early View Articles
Over 45 Early View articles are available on-line.

Value in Health >>

 

ISPOR CONNECTIONS

 

NEW!
ISPOR CONNECTIONS Volume 15, Issue 1 Now On-Line
ISPOR CONNECTIONS Volume 15, Issue 1 is now available on-line. Articles include, “Rasch Models of Item Response in Health-Related Quality-of-Life (HRQoL) Instruments,” “Country-to-Country Adaptation of Pharmacoeconomic Research: Methodologic Challenges and Potential Solutions,” and “The Appropriateness of Prescription Restrictions as a Policy Tool."

ISPOR CONNECTIONS Volume 15, Issue 1 >>

 

SPECIAL INTEREST GROUPS/TASK FORCES

 

Health Technology Assessment (HTA) Special Interest Group
NEW!

HTA of Medical Devices and Diagnostics Working Group

Chair: Annie Chicoye, Senior Principal Director Pricing & Market Access IMS Consulting, Puteaux cedex,France.
The group’s goal is to develop information on the health care reimbursement systems and decision-making processes for medical devices and diagnostics around the world.
For more information on this group, see:

Health Technology Assessment Special Interest Group >>

Global Health Care Reimbursement Systems and Decisions Processes Working Group is adding more countries to the ISPOR Global Health Care Systems Road Map. ISPOR members interested in adding countries to the Road Map, please contact: reldessouki@ispor.org.

NEW!

Personalized Medicine Special Interest Group

Chair: Eric Faulkner, MPH Senior Director, RTI Health Solutions, and Executive Director, Genomics Biotech Institute, National Association of Managed Care Physicians, Research Triangle Park, NC, USA.
There is an ongoing trend in the health care environment towards personalized medicine / pharmacogenomics.  While until recently most treatments were applied broadly (with varying success), increasingly, treatment is becoming tailored to selected patient groups defined for instance by molecular markers.  This concept can be defined quite broadly, including risk assessment, screening and diagnosis, prognosis, prediction of response and monitoring of response.  The goal of this new SIG is to develop good research practices on the design of studies involved in personalized medicine, a checklist on study attributes for publications of personalized medicine research studies, and taxonomy of terms used in personalized medicine. For more information on this group, see:

ISPOR Personalized Medicine Special Interest Group >>

 

NEW!

Indirect Treatment Comparisons Good Research Practices
Task Force

Chair: Lieven Annemans PhD, MSc, Mman, Professor of Health Economics, Ghent University and Brussels University, Meise, Belgium.

This Task Force will develop good research practices on indirect treatment comparisons that address key issues from an outcomes researcher’s perspective as well as key issues from a health care decision maker’s perspective. For more information on this Task Force, see:

Indirect Treatment Comparisons Good Research Practices >>

 

NEW!

Conjoint Analysis Good Research Practices Task Force
Chair: John F.P. Bridges PhD, Assistant Professor, Department of Health Policy & Management Johns Hopkins Bloomberg School of Public Health

Conjoint analysis and other methods to measure patient and other stakeholder preferences are increasingly being used in outcomes research as a means to identify and evaluate the relative importance of aspects of health outcomes and health care services.  There persists significant variability in the quality of conjoint analysis methods. To overcome this application & quality variability, a means to assess good research practices is needed to promote adoption of better methods. For more information on this Task Force, see:

ISPOR Conjoint Analysis Good Research Practices Task Force >>

 

ISPOR REGIONAL CHAPTER NEWS

 

NEW!

ISPOR Slovakia Regional Chapter Meeting

On April 6, 2009 there will be a 2nd ISPOR Slovakia Regional Chapter Congress held at the Radisson SAS Carlton Hotel Bratislava, Bratislava, Slovakia. 

ISPOR Slovakia Regional Chapter >>

 

ISPOR Serbia Regional Chapter Meeting

On March 9-10, 2009 there will be an ISPOR Serbia Regional Chapter Congress held at the Sava Center, Novo Sad, Serbia.

ISPOR Serbia Regional Chapter >>

 

NEW!

ISPOR Latin America Consortium Chair

ISPOR is pleased to announce the 2008-2010 Chair for the ISPOR Latin America Consortium Advisory Committee, Lou Garrison PhD, Professor, University of Washington, Department of Pharmacy, Seattle, WA, USA.
ISPOR Latin America Consortium >>

 

TIP OF THE MONTH- ISPOR Website Site Map
The Site Map on the ISPOR homepage gives you a quick and comprehensive look at the ISPOR website and provides over 20 ISPOR areas of interests and links to many useful resources. To access the ISPOR Site Map, simply click the Site Map Link on the ISPOR website homepage.

 

********************Advertisements**********************

 

Measurement, Design, and Analysis Methods for Health Outcomes Research

August 17–19, 2009

Harvard School of Public Health, Boston, MA, USA

 

Don’t let a weak economy keep you from obtaining essential knowledge in outcomes studies. Leverage the current economic landscape as a chance to outpace your competition. Discover new ideas that will strengthen your workplace and boost your bottom line — key elements of success during these challenging times.

 

Taught in an interactive classroom setting, this program is geared towards introductory to intermediate learning levels to help participants design, implement, and analyze outcomes studies, and critically review and use outcomes data for clinical decision making, health care planning, and technology development. 95% of participants rated the overall program as exceeding their expectations.

 

Register Today!

 

Practical, Small Group, Learning Sessions with Topics Including:

    * Structural Equation Modeling

    * Outcomes Measurement

    * Health Economics

    * Psychometrics

    * Statistical Methods

 

Group Discounts Available: Register with a colleague and receive a 15% discount on each full tuition. Receive a 20% discount when three of more colleagues from your organization register. That means, when you participate with 4 colleagues, a 5th colleague can attend tuition free! This is an excellent professional development opportunity that can serve as a strategy building retreat for your team. Please email us at: contedu@hsph.harvard.edu or call us at: 617-384-8692 for more information.

 

What Participants Are Saying

 “The wealth of knowledge and expertise among the panel of speakers was demonstrated time and time again. There was a great variety in content, from reviews of basic outcomes and research fundamentals, to cutting edge presentations on current issues in health outcomes research — all from experts in the field!” — Brenda Marie Parker, PharmD, Clinical Pharmacist, Humana Pharmacy Solutions, Louisville, KY, USA.

 

“Provides excellent tools and guidelines for assessing a program’s cost-effectiveness. These and other concrete tips, such as how to assess the validity, reliability, and responsiveness of quality improvement tools and scales, will enhance my efforts to better evaluate and provide data towards our efforts.”  

— Dominique Kim, Program Manager, Partners Health Care System, Needham, MA, USA.

 

CME and CEU Credits Available. For a detailed agenda or to register, visitHarvard School of Public Health, Center for Continuing Professional Education or call (617) 384-8692.  Please be sure to mention your Reference Code:  MDA09-IP01 in all correspondence. 

 

This program is recognized by the Society for Risk Analysis.

 


 

 

MSc in Health Economics Policy and Management

 

Founded in 1895, the London School of Economics and Political Science is now the world’s leading dedicated social science institution.

 

The School is offering health care, pharmaceutical and public sector professionals a unique opportunity to work full time and gain formal qualifications at the same time in topics such as

  • health management and administration
  • health economics
  • cost-effectiveness and statistical analysis
  • health policy
  • pharmaceutical economics
  • epidemiology/clinical trials
  • health information systems

 This modular MSc programme is operated by LSE Health and the Department of Social Policy at the London School of Economics and Political Science.

 

Additional teaching is provided by the Department of Management and the European Institute as well as subject experts from other UK academic institutions. 

 

The programme starts in December 2009.  The MSc will take two years to complete with two intensive sessions each academic year - December 2009, June 2010, December 2010 and June 2011. 

 

The MSc will require a total of 41 days in London for teaching and examinations over two years with extensive off-site support in-between.

 

Diploma and certificate options are also available.

 

For additional information please contact: HEPM@lse.ac.uk

 

********************Advertisements**********************


This newsletter is provided as a benefit of membership in ISPOR. If you received this from a colleague and are not a current ISPOR member, please consider becoming an individual member or organizational affiliate.  Contact membership services for more information and its use in health care decisions.

 

The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research.


3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA

Tel: 609-219-0773 Toll Free: 1-800-992-0643 Fax: 609-219-0774

 

IMPORTANT DATES TO REMEMBER

 

19 March 2009

 ISPOR 2nd Latin America Conference Abstract Deadline
More >>

 

April 7, 2009

ISPOR 14th Annual International Meeting Registration Deadline
More >>

 

May 16-20, 2009

ISPOR 14th Annual International Meeting

More >>

 

23 June 2009

ISPOR 12th Annual European Congress Abstract Deadline

More >>

 

10-12 September 2009

ISPOR 2nd Latin America Conference
More >>

 

24-27 October 2009

ISPOR 12th Annual European Congress
More >>

 

QUICK LINKS

 

ISPOR 14th Annual International Meeting

 

ISPOR 2nd Latin America Conference

 

ISPOR 12th Annual European Congress

 

Value in Health

 

ISPOR CONNECTIONS

 

ISPOR Research Digest

 

ISPOR Book of Terms

 

ISPOR Good Research Practices

 

Special Interest Groups (SIGs)

 

ISPOR Student Network

 

ISPOR Chapters

 

ISPOR Latin America Consortium

 

ISPOR Asia Consortium

 

Membership

 

Employment